What is new in the epidemiology of lung cancer: Non-smokers, women and the role of cannabis?;Nouveautés épidémiologiques du cancer bronchique. Les non-fumeurs, les femmes, les fumeurs de cannabis

Revue du Praticien

Volumn 59, Issue 7, 2009, Pages 920-924

  Quoix, Elisabeth ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CANNABIS; TOBACCO SMOKE;

AGING; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; HUMAN; LUNG CANCER; OCCUPATIONAL HAZARD; REVIEW; SEX RATIO; SMOKING; ARTICLE; CANNABIS SMOKING; FEMALE; LUNG TUMOR; MALE; RISK FACTOR; SEX DIFFERENCE;

FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MARIJUANA SMOKING; RISK FACTORS; SEX FACTORS;

EID: 70349740984     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Quoix E, Mennecier B. Cancer du poumon et pollution. Rev Pneumol Clin 2003;59:187-195
3. Wakelee HA, Chang ET, Gomez SL, et al. Lung cancer incidence in never smokers. J Clin Oncol 2007;25: 472-478 (Pubitemid 350002951)
4. Blair A, Freeman LB. Lung cancer among nonsmokers. Epidemiology 2006;17:601-603
5. Foegle J, Hedelin G, Lebitasy MP, Purohit A, Velten M, Quoix E. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997. J Thorac Oncol 2007;2:466-474
6. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2:506-513
7. Minami H, Yoshimura M, Miyamoto Y, Matsuoka H, Tsubota N. Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer. Chest 2000;118:1603-1609 (Pubitemid 32001783)
8. Lebitasy M, Monnet I, Depierre A, et al. Management of elderly lung cancer patients in France: a national prospective survey by the French Intergroup of thoracic Oncology (IFCT). J Clin Oncol 2004;22:8163.
9. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156
10. Belot A, Grosclaude P, Bossard N, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008;56:159-175
11. Borras JM, Fernandez E, Gonzalez JR, et al. Lung cancer mortality in European regions (1955-1997). Ann Oncol 2003;14:159-161
12. Jemal A, Cokkinides VE, Shafey O, Thun MJ. Lung cancer trends in young adults: an early indicator of progress in tobacco control (United States). Cancer Causes Control 2003;14:579-585 (Pubitemid 36999972)
13. Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Santé Publique 2003;51:3-30.
14. Perneger TV. Sex, smoking, and cancer a reappraisal. J Natl Cancer Inst 2001;93:1600-1602
15. Kure EH, Ryberg D, Hewer A, et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis 1996;17:2201-2205 (Pubitemid 26372059)
16. Tang DL, Rundle A, Warburton D, et al. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis 1998;19:1949-1953 (Pubitemid 28521936)
17. Shriver SP, Bourdeau HA, Gubish CT, et al. Sex-specific expression of gastrin-releaslng peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 2000;92:24-33.
18. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 2000:75-93.
19. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2:506-513
20. Tsao MS, Sakurada A, Cutz JC, et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med 2005;353:133-144 (Pubitemid 41058345)
21. Janne PA, Engelman JA, Johnson BE. Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol 2005; 23:3227-3234 (Pubitemid 46211347)
22. Tricker AR. Re: environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 2000;92:760-761 (Pubitemid 30365541)
23. Tracy BL, Krewski D, Chen J, Zielinski JM, Brand KP, Meyerhof D. Assessment and management of residential radon health risks: a report from the health Canada radon workshop. J Toxicol Environ Health A 2006;69:735-758
24. Xu ZY, Blot WJ, Xiao HP, et al. Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst 1989;81:1800-1806 (Pubitemid 20001424)
25. Yu IT, Chiu YL, Au JS, Wonng TW, Tang JL. Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. Cancer Res 2006;66:4961-4967
26. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-351 (Pubitemid 39093415)
27. Chartoux A, Rossignol M, Purohit A, et al. International differences in epidemiology of lung adenocarcinoma. Lung Cancer 1997;16:133-143 (Pubitemid 27215807)
28. Kubina M, Hedelin G, Chartoux A, Purohit A, Pauli G, Quoix E. Les patients ayant un carcinome maipighien et ceux ayant un adénocarcinoma bronchique ont-ils une histoire tabagique différente ? Rev Mal Respir 1999;16:539-549
29. Aldington S, Harwood M, Cox B, et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008;31:280-286 (Pubitemid 351288442)
30. Berthiller J, Straif K, Boniol M, et al. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 2008;3: 1398-1403
31. Hashibe M, Straff K, Tashkin DP, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005;35:265-275 (Pubitemid 41079926)